Combined Treatment with Neutralizing Antibodies to IL-1{alpha} / {beta} and TNF{alpha} / PGE2 in a Late Therapeutic Mode Ameliorates Inflammation and Inflammatory Bone Loss in a mouse Collagen Induced Arthritis (mCIA) model of Rheumatoid Arthritis